EBOS Group Ltd
NZX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
NZX:EBO
Watchlist
Price: 37.6 NZD 0.91% Market Closed
Market Cap: 7.3B NZD
Have any thoughts about
EBOS Group Ltd?
Write Note

Intrinsic Value

The intrinsic value of one EBO stock under the Base Case scenario is 55.13 NZD. Compared to the current market price of 37.6 NZD, EBOS Group Ltd is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EBO Intrinsic Value
55.13 NZD
Undervaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
EBOS Group Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EBO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EBO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about EBOS Group Ltd

Provide an overview of the primary business activities
of EBOS Group Ltd.

What unique competitive advantages
does EBOS Group Ltd hold over its rivals?

What risks and challenges
does EBOS Group Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for EBOS Group Ltd.

Provide P/S
for EBOS Group Ltd.

Provide P/E
for EBOS Group Ltd.

Provide P/OCF
for EBOS Group Ltd.

Provide P/FCFE
for EBOS Group Ltd.

Provide P/B
for EBOS Group Ltd.

Provide EV/S
for EBOS Group Ltd.

Provide EV/GP
for EBOS Group Ltd.

Provide EV/EBITDA
for EBOS Group Ltd.

Provide EV/EBIT
for EBOS Group Ltd.

Provide EV/OCF
for EBOS Group Ltd.

Provide EV/FCFF
for EBOS Group Ltd.

Provide EV/IC
for EBOS Group Ltd.

Show me price targets
for EBOS Group Ltd made by professional analysts.

What are the Revenue projections
for EBOS Group Ltd?

How accurate were the past Revenue estimates
for EBOS Group Ltd?

What are the Net Income projections
for EBOS Group Ltd?

How accurate were the past Net Income estimates
for EBOS Group Ltd?

What are the EPS projections
for EBOS Group Ltd?

How accurate were the past EPS estimates
for EBOS Group Ltd?

What are the EBIT projections
for EBOS Group Ltd?

How accurate were the past EBIT estimates
for EBOS Group Ltd?

Compare the revenue forecasts
for EBOS Group Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of EBOS Group Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of EBOS Group Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of EBOS Group Ltd compared to its peers.

Compare the P/E ratios
of EBOS Group Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing EBOS Group Ltd with its peers.

Analyze the financial leverage
of EBOS Group Ltd compared to its main competitors.

Show all profitability ratios
for EBOS Group Ltd.

Provide ROE
for EBOS Group Ltd.

Provide ROA
for EBOS Group Ltd.

Provide ROIC
for EBOS Group Ltd.

Provide ROCE
for EBOS Group Ltd.

Provide Gross Margin
for EBOS Group Ltd.

Provide Operating Margin
for EBOS Group Ltd.

Provide Net Margin
for EBOS Group Ltd.

Provide FCF Margin
for EBOS Group Ltd.

Show all solvency ratios
for EBOS Group Ltd.

Provide D/E Ratio
for EBOS Group Ltd.

Provide D/A Ratio
for EBOS Group Ltd.

Provide Interest Coverage Ratio
for EBOS Group Ltd.

Provide Altman Z-Score Ratio
for EBOS Group Ltd.

Provide Quick Ratio
for EBOS Group Ltd.

Provide Current Ratio
for EBOS Group Ltd.

Provide Cash Ratio
for EBOS Group Ltd.

What is the historical Revenue growth
over the last 5 years for EBOS Group Ltd?

What is the historical Net Income growth
over the last 5 years for EBOS Group Ltd?

What is the current Free Cash Flow
of EBOS Group Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for EBOS Group Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
EBOS Group Ltd

Current Assets 3B
Cash & Short-Term Investments 216.9m
Receivables 1.5B
Other Current Assets 1.3B
Non-Current Assets 3.8B
Long-Term Investments 89.4m
PP&E 834.4m
Intangibles 2.6B
Other Non-Current Assets 240.5m
Current Liabilities 3.1B
Accounts Payable 2.2B
Accrued Liabilities 81.8m
Other Current Liabilities 830m
Non-Current Liabilities 1.2B
Long-Term Debt 820m
Other Non-Current Liabilities 348.6m
Efficiency

Earnings Waterfall
EBOS Group Ltd

Revenue
13.2B AUD
Cost of Revenue
-11.6B AUD
Gross Profit
1.6B AUD
Operating Expenses
-1.2B AUD
Operating Income
482.5m AUD
Other Expenses
-211m AUD
Net Income
271.5m AUD

Free Cash Flow Analysis
EBOS Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EBO Profitability Score
Profitability Due Diligence

EBOS Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
Positive Free Cash Flow
Positive 1-Year Revenue Growth
Positive 3-Year Average ROE
50/100
Profitability
Score

EBOS Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

EBO Solvency Score
Solvency Due Diligence

EBOS Group Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
43/100
Solvency
Score

EBOS Group Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EBO Price Targets Summary
EBOS Group Ltd

Wall Street analysts forecast EBO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EBO is 40.2 NZD with a low forecast of 36.52 NZD and a high forecast of 44.87 NZD.

Lowest
Price Target
36.52 NZD
3% Downside
Average
Price Target
40.2 NZD
7% Upside
Highest
Price Target
44.87 NZD
19% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EBO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EBO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

EBOS Group Ltd Logo
EBOS Group Ltd

Country

New Zealand

Industry

Health Care

Market Cap

7.3B NZD

Dividend Yield

1.49%

Description

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.

Contact

CHRISTCHURCH
108 Wrights Road
+6433380999.0
www.ebosgroup.com

IPO

1986-06-16

Employees

-

Officers

Chief Executive Officer
Mr. John Cullity
Chief Financial Officer
Mr. Alistair Gray
Chief Accountant & Chief Risk Officer
Mr. Leonard Hansen
Chief Information Officer
Mithran Naiker
General Counsel
Ms. Janelle Cain
Group General Manager of Human Resources
Ms. Jacinta McCarthy
Show More
Executive General Manager of Strategic Operations, ESG & Innovation
Mr. Simon Bunde
Chief Executive Officer of Animal Care
Ms. Julie Dillon
Chief Executive Officer of Symbion
Mr. Brett Barons
Show Less

See Also

Discover More
What is the Intrinsic Value of one EBO stock?

The intrinsic value of one EBO stock under the Base Case scenario is 55.13 NZD.

Is EBO stock undervalued or overvalued?

Compared to the current market price of 37.6 NZD, EBOS Group Ltd is Undervalued by 32%.

Back to Top